MedPath

Metamfetamine

Generic Name
Metamfetamine
Brand Names
Desoxyn
Drug Type
Small Molecule
Chemical Formula
C10H15N
CAS Number
537-46-2
Unique Ingredient Identifier
44RAL3456C
Background

Metamfetamine (methamphetamine) is a psychostimulant and sympathomimetic drug, and a member of the amphetamine group of sympathomimetic amines. Methamphetamine can induce effects such as euphoria, increased alertness and energy, and enhanced self-esteem. It is a scheduled drug in most countries due to its high potential for addiction and abuse.

The FDA withdrew its approval for the use of all parenteral drug products containing methamphetamine hydrochloride, a metamfetamine salt.

Indication

For the treatment of Attention Deficit Disorder with Hyperactivity (ADHD) and exogenous obesity.

Associated Conditions
Attention Deficit Hyperactivity Disorder (ADHD), Narcolepsy, Refractory exogenous obesity
Associated Therapies
-
king5.com
·

Washington state's cannabis industry braces for change as federal reclassification considered

Federal reclassification of marijuana could impact Washington state's cannabis industry and research, with potential benefits and challenges for consumers and small businesses.
newsfilecorp.com
·

Safe Supply Streaming Portfolio Company Safety Strips Launches Affordable and Reliable Drug Detection Strips

Safe Supply Streaming's portfolio company, Safety Strips, launches affordable drug detection strips to combat fentanyl, xylazine, and drink spiking, in response to new California legislation. The strips will be available via Greenlane Holdings' distribution channels starting September 25, 2024.
finance.yahoo.com
·

Safe Supply Streaming Portfolio Company Safety Strips Launches Affordable and Reliable ...

Safe Supply Streaming Co Ltd. launches Safety Strips Inc. to combat fentanyl, xylazine, and drink spiking, aligning with California's AB 1013 legislation. Products available from September 25, 2024, through Greenlane Holdings' distribution network.
altoonamirror.com
·

Deal reached in prison overdose

The estate of Kaitlyn Evans, who died of a drug overdose in Clearfield County Prison, seeks court approval for a $1 million settlement. Evans, 32, was found dead in her cell after two other inmates overdosed. The lawsuit alleges prison staff were 'deliberately indifferent' to her medical needs. The settlement is the second in a year involving deaths at the prison, prompting security improvements.
rv-times.com
·

Jackson County's deflection program to prioritize Greenway | Crime & Justice

Jackson County's new deflection program, launching Oct. 7, offers resources and incentives for those caught with small amounts of drugs to seek treatment, dropping criminal charges if they comply with treatment requirements, including 10 meaningful engagements with counselors.
yachatsnews.com
·

Lincoln County hopes to have new state-funded drug "deflection" programs running by ...

Oregon's drug decriminalization law changes lead to better arrest options for low-level offenders, offering treatment or jail. Lincoln County's program, funded by $341,256, faces delays and internal debate over the deflection coordinator's placement, currently unresolved.
theconversation.com
·

A new fentanyl vaccine looks promising – but treating drug addiction needs a more complex ...

A fentanyl vaccine shows promise in rats, preventing the drug's euphoric effects by blocking its action on mu opioid receptors. The vaccine, specific to fentanyl, is set for human trials and could aid in opioid addiction treatment, though it's not a standalone solution. Other drug dependency vaccines have shown limited success, highlighting the need for comprehensive addiction treatments including psychotherapy.
propublica.org
·

How Arizona's Medicaid Fraud Crackdown Hurt Native American Patients

Arizona's Medicaid fraud investigation led to suspension of contracts with hundreds of substance treatment clinics, leaving patients without care. A state hotline for displaced patients showed over 575 callers ended up unsheltered, increasing relapse risks. Some clinics cleared of allegations struggled financially, unable to serve former patients due to denied claims. The crisis particularly affected Native American communities, with many facilities not accepting new American Indian Health Program patients. Patients like Rainy, a 7-year-old with trauma history, regressed without counseling, highlighting the human impact of the Medicaid scandal.

Keynoter Doug Long Sees Fragility, 'Pretty Anemic' Launches As He Looks Ahead to Retirement

Doug Long, IQVIA's VP of industry relations, warns of a fragile U.S. healthcare system in his PBMI keynote, citing issues like low cancer screening rates, poor returns for generic/biosimilar manufacturers, and pharmacy deserts. He criticizes the Inflation Reduction Act, noting only 26 new drugs launched in 2023, and 22 FDA approvals. Long, retiring next May, highlights challenges in retail pharmacy, opioid overdoses, prescription rejections, and declining oncology drug launches.
wmur.com
·

Key FDA researcher who evaluated OxyContin for agency now lives in northern New Hampshire town

Littleton, NH, a picturesque mountain town, faces a severe opioid crisis, with 10 overdose deaths in 2017. Dr. Curtis Wright, a former FDA researcher who approved OxyContin and later worked for Purdue Pharma, resides there. The community, led by Police Chief Paul Smith, focuses on engagement over enforcement, with seven sober living homes now aiding recovery.
© Copyright 2025. All Rights Reserved by MedPath